Comments

Entero Therapeutics

Q: What sector and industry does Entero Therapeutics (ENTO) operate in?

Entero Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

ENTONASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

$0.5899

-0.03-4.85%

At close: -

$0.5987

0.008801.49%

After Hours: Jan 10, 4:33 PM EDT

Entero Therapeutics (ENTO) Forecast

News Earnings Entero Therapeutics (ENTO) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Entero Therapeutics (NASDAQ:ENTO) Stock Quotes, Forecast and News Summary

Entero Therapeutics Stock (NASDAQ: ENTO) stock price, news, charts, stock research, profile.

Open	$0.62
Close	$0.59
Volume / Avg.	62.73K / 282.31K
Day Range	$0.58 - $0.62
52 Wk Range	0.19 - 3.16
Market Cap	$2.85M
P/E Ratio	0.04
Dividend Yield	-
Exchange	NASDAQ
RSI	52
Short Interest	-
Days to Cover	1.27

Recent News

Why Exicure Shares Are Trading Higher By Over 49%; Here Are 20 Stocks Moving Premarket

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Open	$0.62
Close	$0.59
Volume / Avg.	62.73K / 282.31K
Day Range	$0.58 - $0.62
52 Wk Range	0.19 - 3.16
Market Cap	$2.85M
P/E Ratio	0.04
Dividend Yield	-
Exchange	NASDAQ
RSI	52
Short Interest	-
Days to Cover	1.27

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Entero Therapeutics (ENTO) stock?

You can purchase shares of Entero Therapeutics (NASDAQ:ENTO) through any online brokerage.

View our list of the best stock brokerages

Who are Entero Therapeutics (ENTO) competitors?

Other companies in Entero Therapeutics’s space includes: Ultragenyx Pharmaceutical (NASDAQ:RARE), Avidity Biosciences (NASDAQ:RNA), BeiGene (NASDAQ:ONC), Sarepta Therapeutics (NASDAQ:SRPT) and Neurocrine Biosciences (NASDAQ:NBIX).

What is the forecast, or price target, for Entero Therapeutics (ENTO) stock?

There is no analysis for Entero Therapeutics to provide a consensus price target.

What is the current price for Entero Therapeutics (ENTO)?

The stock price for Entero Therapeutics (NASDAQ: ENTO) is $0.5987 last updated January 10, 2025 at 4:33 PM EST.

Does Entero Therapeutics (ENTO) pay a dividend?

There are no upcoming dividends for Entero Therapeutics.

When is Entero Therapeutics (NASDAQ:ENTO) reporting earnings?

Entero Therapeutics’s Q3 earnings are confirmed for Wednesday, November 13, 2024.

Is Entero Therapeutics (ENTO) going to split?

There is no upcoming split for Entero Therapeutics.

What sector and industry does Entero Therapeutics (ENTO) operate in?

Entero Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.